PCM-induced nephrotoxicity has been previously documented by a number of studies [17]. In this study a clear elevation of urea and creatinine in the PCM-alone group provided evidence that the administration of 500 mg/kg of PCM induced kidney injury. Creatinine is produced from the metabolism of protein in muscles, with most creatinine being filtered out of the blood by the kidney and excreted in urine. In renal disease, serum urea accumulates and causes uremia because the rate of serum urea production exceeds the rate of clearance [18]. The significantly high blood urea in the PCM-treated group suggests kidney injury. PCM-induced nephrotoxicity is caused by the toxic effect of N-acetyl-p-benzoquinone imine (NAPQI). PCM is oxidized by cytochrome p-450 and produces the reactive intermediate metabolite NAPQI [19]. Another factor in PCM toxicity is the formation of reactive oxygen species (ROS), especially superoxide anions. The nephrotoxicity caused by ROS and NAPQI is largely counteracted by glutathione in the early stages of toxicity (Miettinen and Bjorklund, 2014). However, after the depletion of glutathione, NAPQI covalently binds with sulfhydryl groups of proteins in later stages of toxicity [20]. The significant decrease (P < 0.05) in serum total protein and albumin in the PCM-treated group (Table 2) could be due to arylation of protein by NAPQI [20]. Protein content in the blood in V. origena-treated groups (100 and 200 mg/kg) was significantly increased compared to the PCM-treated group, providing evidence that V. origena may be able to minimize the toxic effect of PCM. Also, the creatinine clearance in urine improved with Acacia senegal administration [21].
The present study showed that proximol has similar effects in controlling serum biochemical parameters in PCM-induced toxicity in guinea pigs. Also, administration of V. origena at 100 mg/kg and 200 mg/kg concurrently with PCM significantly inhibited the rise in kidney injury markers, i.e., urea and creatinine, compared to the PCM-treated group, which revealed the ability of V. origena to eliminate creatinine from blood into urine, eventually normalizing creatinine content in the blood, which may be attributed to its protective effect on the cell by the prevention of free radical production. Lipid peroxidation is characterized as the procedure of oxidative debasement of polyunsaturated fatty acids and leads to weakened membrane function and structural integrity. V. origena may diminish the level of free radicals responsible for lipid peroxidation and thus decrease the level of malondialdehyde. This reveals that V. origena has the potential of scavenging free radicals and lessening PCM-instigated free-radical damage, which is confirmed by the histological results. Administration of V. origena extract improves oxidative stress via numerous mechanisms that incorporate a decreased level of free radicals like superoxide and preservation of total antioxidant capacity through maintaining near-normal activity levels of endogenous enzymatic/non-enzymatic antioxidants. The later impacts might be credited to a higher level of total phenolic contents, flavonoids, tannins, saponins, alkaloids, steroids, and carbonyl in the V. origena extract, as displayed by phytochemical examination [12].
The biochemical results were also confirmed by the histological findings, which showed that, the oral administration of PCM caused severe damage to the kidney, with tubular degeneration, wide lumen, damaged glomeruli, interstitial vascular congestion, and epithelial degeneration, whereas V. origena pretreatment resulted in significant dose-dependent nephroprotection against PCM- induced nephrotoxicity. Most drugs induce renal injuries that affect the proximal tubules, glomerulus, or more distal parts of the nephron [22]. The results of this study were in agreement with the results of another study carried out on Acacia sp. by Osman et al., (2022) [23], who showed that there was a significant (p < 0.05) increase in serum creatinine and blood urea levels in the PCM-treated group compared to the control groups due to nephrotoxicity. Treatment with Acacia senegal showed a significant decrease in serum urea levels compared to the PCM-treated group. Histopathological examination of the rat kidneys revealed severe degeneration in the PCM-treated group, while there was evidence of significant protection in the plant extract-treated groups against PCM-induced changes. The serum and urine biochemical results and histopathology analysis of the kidney indicated the nephroprotective potential of Acacia senegal extract against PCM-induced nephrotoxicity. Also, the results of the present study were in agreement with Hala et al., (2022) [24], who found that the administration of A. senegal aqueous extract followed by treatment with gentamicin improved the activity of protein and albumin towards the normal values in plant extract-treated groups, while it was reduced significantly in the group treated only with gentamicin. There was a significant elevation in urea and creatinine levels in the gentamicin-treated group, and there was a significant reduction in urea and creatinine levels in the Acacia senegal-treated groups at 250 and 500 mg/kg.
The results of the present study provided the first experimental evidence that V. origena ethanol extract prevents the kidney parameters, such as urea, creatinine, and total proteins, as well as albumin concentrations, from gradually increasing after induction by PCM and they were kept at mean normal values in comparison with the positive control, which was induced by PCM and caused kidney cell damage.